JGGDR
CBIO icon

JGP Global Gestao de Recursos’s Crescent Biopharma CBIO Stock Holding History

JGP Global Gestao de Recursos’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-101
Closed -$126K – 70
2019
Q1 		$126K Buy
+101
New +$116K 0.05% 62

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JGP Global Gestao de Recursos's CBIO Position: Q2 2019 in Review

JGP Global Gestao de Recursos sold out of Crescent Biopharma (CBIO) in Q2 2019, closing a stake of 101 shares — an estimated $126K sold.

JGP Global Gestao de Recursos first reported a position in CBIO in Q1 2019 and held it in 1 quarter. The position peaked at $126K in Q1 2019. 78 funds tracked by Wall St. Rank hold CBIO as of Q2 2019.

  • JGP Global Gestao de Recursos reported no remaining Crescent Biopharma position as of Q2 2019 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 101 Crescent Biopharma shares in Q2 2019, an estimated $126K.
  • JGP Global Gestao de Recursos first reported a position in Crescent Biopharma in Q1 2019 and held it in 1 quarter.
  • JGP Global Gestao de Recursos's Crescent Biopharma position peaked at $126K in Q1 2019.
  • 78 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2019.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2019, filed 19 Jul 2019.